STAT3 and ovarian carcinoma: The anticancer analogs from curcumin, diarylidenyl piperidone (DAP) derivatives such as HO-3867, HO-4200, HO-4318, inhibit STAT3 activity and sensitize drug-resistant ovarian carcinoma and clear cell carcinoma cells to paclitaxel or cisplatin [52,156,157,158].